DOSSIER · 13F Holders · Q2 2026
ENLIVEX THERAPEUTICS LTD
30 institutions still hold ENLIVEX THERAPEUTICS LTD as of Q2 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP M4130Y106·30 13F holders·last filed Jun 30, 2026
AI Holders Summary · Q2 2026
30 institutions reported ENLIVEX THERAPEUTICS LTD in Q2 2026. ARK Investment Management LLC leads at 52.1% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.
Page 1 of 2
10 more holders available. Log in →